Should You Avoid Retinyl Palmitate in Sunscreens?

The assertion that retinyl palmitate, a common vitamin A derivative found in sunscreens, increases the risk of skin cancer has recently gained renewed attention, primarily fueled by "clean beauty" advocates and social media figures. This claim, often highlighted by organizations such as the Environmental Working Group (EWG) in their annual sunscreen guides and amplified by toxicologists like Dr. Yvonne Burkart in viral online content, suggests a paradoxical danger in a product designed to protect against sun damage. However, a comprehensive review of scientific evidence by cosmetic scientists and toxicologists, including Michelle Wong of Lab Muffin Beauty Science and Mohammed Kanadil of MoSkinLab, strongly refutes this notion, emphasizing that official regulatory bodies have consistently deemed the ingredient safe for use in sun protection.

The controversy centers on whether retinyl palmitate, when exposed to sunlight on the skin, degrades into compounds that promote oxidative stress and DNA damage, potentially leading to tumor formation. Dr. Yvonne Burkart, in her video "You’ve been lied to about sunscreen: Toxicologist reveals 6 things you should know about sunscreen," positioned this claim as a primary concern, stating that "some [sunscreen] ingredients can actually promote skin cancer." She specifically cited retinyl palmitate as a "synthetic form of vitamin A" often added for its anti-aging benefits, which, she argued, "becomes highly unstable, breaks down into free radicals" when exposed to sunlight. These free radicals, according to Burkart, "damage DNA and lipids, as well as proteins, accelerate skin aging and may even increase the risk of tumor formation over time."

This argument is not new, echoing sentiments that have circulated within the "clean beauty" sphere for over a decade. The movement, which advocates for products free from synthetic chemicals perceived as harmful, has significantly influenced consumer perceptions, often prioritizing natural or organic ingredients over those with robust scientific safety profiles. The EWG, a prominent voice within this movement, has regularly flagged retinyl palmitate in its sunscreen hazard scores, contributing to widespread consumer anxiety.

However, the scientific community, particularly those involved in cosmetic toxicology and dermatology, maintains a different perspective. Wong and Kanadil, collaborating with experienced toxicologists Dr. Norbert Kaminski and Dr. Lyle Burgoon, systematically dismantled these claims in a detailed response, which they subjected to expert review. Their analysis highlights a critical distinction between preliminary experimental findings and comprehensive safety assessments conducted by official regulatory bodies.

Examining the Evidence: In Vitro, Cell, and Animal Studies

The arguments against retinyl palmitate typically cite three main categories of scientific studies:

1. In Vitro Experiments: These are test-tube studies where retinyl palmitate is exposed to UV radiation, showing it can break down to form reactive oxygen species (ROS). ROS are known to induce oxidative stress, a process implicated in cellular damage and potentially in the initiation of cancer.
2. Cell Studies: Experiments involving cells grown in petri dishes have indicated that when these cells are exposed to UV light in the presence of retinyl palmitate, they exhibit an increased rate of mutation.
3. Animal Studies: The most frequently referenced animal study is a 2012 report by the National Toxicology Program (NTP) titled "Photocarcinogenesis study of retinoic acid and retinyl palmitate […] in SKH-1 mice." This study, often cited by critics, found that hairless mice treated topically with retinyl palmitate and exposed to simulated sunlight developed significantly more skin tumors compared to control groups exposed only to simulated sunlight. Dr. Burkart specifically referred to this, stating it was "even more concerning."

While these findings might appear alarming in isolation, toxicologists and regulatory experts emphasize the need for careful interpretation within the broader context of toxicology and human physiology. The limitations of these study types, particularly their applicability to human skin under real-world conditions, are crucial for a balanced safety assessment.

Regulatory Scrutiny: The European Union’s SCCS Assessment

Far from being overlooked, these studies have been rigorously evaluated by expert panels, notably the European Union’s Scientific Committee on Consumer Safety (SCCS). Comprising highly experienced scientists, primarily toxicologists, the SCCS conducts exhaustive safety assessments that are far more detailed and stringent than typical peer-reviewed papers. Their conclusions, based on a holistic review of all available data, serve as the foundation for cosmetic ingredient regulation across the EU.

The SCCS first reviewed vitamin A derivatives, including retinyl palmitate, in 2016, and revisited its opinion in 2022. In both instances, after considering the NTP study and other relevant research, the SCCS concluded that retinyl palmitate is safe for use in sunscreens. Their rationale highlights several key reasons why the concerns raised by in vitro, cell, and certain animal studies do not translate into a human safety risk:

1. In Vitro Experiments Do Not Reflect the Complex Human Skin Environment: Test-tube experiments simplify biological systems, often isolating ingredients from their natural context. Human skin is a complex organ containing a rich array of antioxidants (e.g., vitamin C, vitamin E, glutathione) that scavenge free radicals. In this intricate biological milieu, retinyl palmitate, which itself possesses antioxidant properties, is likely to behave differently than in an isolated test tube. It can function as an antioxidant, potentially decreasing overall oxidative stress rather than increasing it. Therefore, simply observing free radical formation in vitro does not equate to a cancer risk on human skin.

2. Significant Differences Between Hairless Mouse and Human Skin: The NTP study’s use of SKH-1 hairless mice is a critical factor. These mice are specifically chosen for carcinogenicity studies because they are highly susceptible to UV damage and develop tumors rapidly, allowing researchers to observe effects within a shorter timeframe. However, this extreme sensitivity means their skin physiology is vastly different from human skin. Human skin is significantly more adapted to sun exposure, possessing more robust defense mechanisms, including thicker epidermal layers, different melanin distribution, and a more complex antioxidant network. Extrapolating results directly from these hypersensitive animal models to humans is scientifically unsound without further validation. For humans, retinoids might even offer protective benefits against certain types of skin damage.

3. Real-World Data Suggests Retinoids Are Protective: Dermatologists have utilized various forms of retinoids (including retinol and tretinoin) for over 50 years, not only for anti-aging and acne treatment but also for preventing certain forms of skin cancer, such as actinic keratoses and squamous cell carcinoma. Patients undergoing retinoid therapy are often under close dermatological supervision. If retinoids, especially when combined with sun exposure, posed a significant risk of skin cancer, such a widespread and long-standing clinical practice would have undoubtedly revealed this adverse effect by now. The absence of such findings in decades of clinical use provides strong real-world evidence of their safety, and in some cases, protective efficacy.

   

4. Anomalies and Confounding Factors in the NTP Mouse Study: The NTP mouse study itself contained peculiar results that complicated interpretation. For instance, in some groups, higher UV exposure actually led to fewer tumors. Furthermore, the control cream, which lacked retinyl palmitate but contained other ingredients, also caused an increase in tumors compared to untreated mice. This suggests that another ingredient in the cream’s base, specifically diisopropyl adipate, might have been a confounding factor. Diisopropyl adipate has been shown to increase UV sensitivity in hairless mice, though similar effects have not been observed in human skin. These anomalies underscore the difficulty of drawing definitive conclusions solely from this animal study regarding retinyl palmitate’s specific photocarcinogenic potential in humans.

Broader Context: Retinoids in Dermatology and Public Health

The debate surrounding retinyl palmitate in sunscreens reflects a broader tension in public health communication, particularly concerning cosmetic ingredients. While public interest in product safety is crucial, the interpretation of scientific data requires specialized expertise. Regulatory bodies like the SCCS, the U.S. Food and Drug Administration (FDA), and Health Canada, along with professional dermatological associations such as the American Academy of Dermatology (AAD), rely on a consensus of expert opinion derived from comprehensive reviews of all available scientific literature, not just isolated studies.

The SCCS’s cautious approach is further demonstrated by their 2022 report, which recommended restricting the concentration of retinol in skincare products. This recommendation was not due to photocarcinogenicity concerns, but rather to minimize potential increases in overall dietary vitamin A intake from cosmetic sources, given that many individuals already consume significant amounts of vitamin A through food and supplements. This illustrates that these expert committees are indeed vigilant and proactive in recommending restrictions when a plausible risk is identified, reinforcing the credibility of their safety assessments for retinyl palmitate in sunscreens.

The Impact of Misinformation

The persistent promotion of misinformation regarding ingredient safety has significant implications. For consumers, it can lead to unnecessary fear and avoidance of products that offer proven benefits, such as broad-spectrum sunscreens, which are critical for preventing skin cancer. It can also divert attention from truly harmful practices or ingredients, while fostering distrust in established scientific institutions and regulatory oversight.

For the beauty industry, such claims can pressure manufacturers to remove safe and effective ingredients, leading to reformulated products that may be less effective or more costly to produce. It also contributes to the challenge of science communication, where complex toxicological data is often oversimplified or misinterpreted for broader audiences, sometimes inadvertently, sometimes deliberately.

Ultimately, navigating product safety requires consulting authoritative sources that synthesize extensive scientific research. Relying on isolated studies or claims from non-expert sources, especially when these claims contradict official, peer-reviewed safety assessments by expert panels, constitutes a significant red flag. The scientific consensus, supported by regulatory bodies and decades of clinical practice, affirms that retinyl palmitate in sunscreens does not increase skin cancer risk and remains a safe ingredient for consumer use.

References

National Toxicology Program. Photocarcinogenesis study of retinoic acid and retinyl palmitate [CAS Nos. 302-79-4 (All-trans-retinoic acid) and 79-81-2 (All-trans-retinyl palmitate)] in SKH-1 mice (Simulated Solar Light and Topical Application Study). Natl Toxicol Program Tech Rep Ser. 2012;(568):1-352.

Tolleson WH, Cherng SH, Xia Q, et al. Photodecomposition and phototoxicity of natural retinoids. Int J Environ Res Public Health. 2005;2(1):147-155. doi:10.3390/ijerph2005010147

Mei N, Xia Q, Chen L, Moore MM, Fu PP, Chen T. Photomutagenicity of retinyl palmitate by ultraviolet a irradiation in mouse lymphoma cells. Toxicol Sci. 2005;88(1):142-149. doi:10.1093/toxsci/kfi291

Scientific Committee on Consumer Products. Opinion on Vitamin A (Retinol, Retinyl Acetate, Retinyl Palmitate). October 6, 2016.

Scientific Committee on Consumer Safety. Revision of the Scientific Opinion (SCCS/1576/16) on Vitamin A (Retinol, Retinyl Acetate, Retinyl Palmitate). October 24, 2022.